Ausdal Financial Partners, Inc. Bluebird Bio, Inc. Put Options Transaction History
Ausdal Financial Partners, Inc.
- $1.36 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
14Shares Held
20.2MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$76.7 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$23.2 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$208,4510.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$157,2200.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$142,6880.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $383M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...